Mobile Telehealth for Alzheimer's Disease
Trial Summary
What is the purpose of this trial?
This study is a randomized, controlled trial (RCT) to evaluate usability and acceptability, and met and unmet needs from a caregiver intervention app, Brain CareNotes, among unpaid Hispanic caregivers of patients with dementia. Brain CareNotes provides support for management of the behavioral and psychological symptoms of dementia (BPSD) displayed by care recipients. Over 10 months, the trial will enroll 40 Hispanic caregivers of community-dwelling patients diagnosed with Alzheimer's disease or a related dementia (ADRD). Caregivers will be randomized to use the Brain CareNotes app or an attention control education-only app for 12 months, with usage reminders.
Will I have to stop taking my current medications?
The trial information does not specify whether participants need to stop taking their current medications.
What data supports the effectiveness of the treatment Brain CareNotes, Brain CareNotes App, I-CARE 2 Intervention, Dementia Guide Expert for Alzheimer's Disease?
Research shows that digital health interventions, like smartphone apps, can improve care for Alzheimer's patients by providing disease management and caregiver support. Although current apps have limited functions, they have the potential to benefit caregivers and patients by offering information and coordination tools.12345
Is the mobile telehealth app for Alzheimer's disease safe for humans?
How is the Brain CareNotes treatment different from other Alzheimer's treatments?
Brain CareNotes is unique because it is a mobile telehealth app designed to reduce caregiver burden and manage behavioral and psychological symptoms of dementia, offering a digital platform for communication and coordination among care networks, unlike traditional treatments that focus solely on medication or in-person interventions.24567
Research Team
Malaz Boustani, MD, MPH
Principal Investigator
Indiana University
Richard J Holden, PhD
Principal Investigator
Indiana University
Eligibility Criteria
This trial is for unpaid Hispanic caregivers, aged 18 or older, who look after someone with Alzheimer's disease or a related dementia and live in the community. Caregivers must be English literate and able to use a mobile touchscreen device. Those caring for individuals in nursing homes or participating in another conflicting clinical trial cannot join.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants use the Brain CareNotes app or an attention control education-only app for 12 months
Follow-up
Participants are monitored for usability, acceptability, and needs met or unmet by the intervention
Treatment Details
Interventions
- Brain CareNotes
- Dementia Guide Expert
Brain CareNotes is already approved in United States for the following indications:
- Management of behavioral and psychological symptoms of dementia (BPSD)
- Support for unpaid caregivers of patients with dementia
Find a Clinic Near You
Who Is Running the Clinical Trial?
Indiana University
Lead Sponsor
National Institute on Aging (NIA)
Collaborator